Conflicting Interactions of Apolipoprotein a and High Density Lipoprotein Cholesterol With Microvascular Complications of Type 2 Diabetes Publisher Pubmed



Aryan Z^{1, 2} ; Afarideh M¹ ; Ghajar A¹ ; Esteghamati S¹ ; Esteghamati A¹ ; Nakhjavani M¹ Show Affiliations
Source: Diabetes Research and Clinical Practice Published:2017

Abstract

Aims This study is amid at investigating the associations, and interactions of serum lipid biomarkers with microvascular complications of type 2 diabetes (T2D). Methods A nested case-control study was conducted within an ongoing prospective study on patients with T2D. Microvascular complications of T2D including diabetic neuropathy, diabetic retinopathy and diabetic nephropathy were investigated. A total of 444 cases with at least one of the microvascular complications of T2D and 439 age- and gender-matched controls free of any of the chronic microvascular complications of T2D were included. The associations and interactions of a panel of serum lipid biomarkers with the microvascular complications of T2D were investigated. Results Serum triglyceride had the strongest association with microvascular complications of T2D (crude model: β = 0.632, P value = 0.045). Each standard deviation increment in serum TG was associated with 3.7 times increased frequency of microvascular complications. Despite high density lipoprotein cholesterol (HDL-C), serum apolipoprotein A1 (Apo A1) was positively associated with the presence of diabetic neuropathy. Each standard deviation increment in serum ApoA1 was associated with increased frequency of diabetic neuropathy (OR, 1.2, 95% CI, (1.1–1.3), P value = 0.006). The frequency of diabetic neuropathy was higher in 2nd and 3rd quartiles of serum Lp(a) compared to diabetic patients in the first quartile (OR, 5.52, 95% (1.17–25.8), P value = 0.047). Conclusions ApoA1 but not HDL-C is straightly associated with diabetic neuropathy. Even Slight rise in serum Lp(a) is associated with increased frequency of diabetic retinopathLipid variables could serve as specific predictors of vascular complications in diabetes. © 2017 Elsevier B.V.